A Study of TransCon TLR7/8 Agonist With or Without Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors

Clinical trial NCT04799054 · TERMINATED

Trial details

NCT number: NCT04799054
Sponsor: Ascendis Pharma Oncology Division A/S
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor Locally Advanced Solid Tumor Metastatic Solid Tumor Head and Neck Squamous Cell Carcinoma HNSCC HPV-associated Cancers Neoadjuvant Melanoma Neoadjuvant Cutaneous Squamous Cell Carcinoma (cSCC)

Start date: 2021-03-18
Primary completion: 2025-12-02
Enrollment: 188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.